中日友好医院品牌怎么样 申请店铺

我要投票 中日友好医院在男科医院行业中的票数:99 更新时间:2025-02-23
中日友好医院是哪个国家的品牌?「中日友好医院」是 中日友好医院 旗下著名品牌。该品牌发源于北京市,由创始人王院长在1984年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力中日友好医院品牌出海!通过在本页面挂载中日友好医院品牌的产品链接和联系邮箱,可以提高中日友好医院产品曝光!跨境电商爆单神器,目前只要100元/年哦~

中日友好医院怎么样

始于1984年,卫生健康委员会直属大型综合性三级甲等医院,集医疗/教学/科研/康复/预防保健等于一体的现代化综合性医院


中日友好医院(简称“中日医院”)是国家卫生健康委员会直属大型综合性三级甲等医院,于1984年10月23日开院。

中日医院现编制床位1610张(含北区、西区),集医疗、教学、科研和预防保健等多项功能为一体,并承担中央保健医疗任务、国家卫生应急救援队任务,附设中日友好临床医学研究所,同时还是世界卫生组织戒烟与呼吸疾病预防合作中心、国家卫生计生委远程医疗管理与培训中心。

学术方面,王辰院士等在慢阻肺、哮喘、呼吸系感染、呼吸危重症、间质性肺疾病、肺血管病、戒烟等方面取得突出成就,肺栓塞半量溶栓疗法等多项重要创新进入国际诊疗指南;潘孝仁教授、李光伟教授等历时长达20余年进行的“大庆糖尿病预防研究”,被称为2型糖尿病一级预防的里程碑式研究,是国际医学研究的经典;杨文英教授团队发表于《新英格兰医学杂志》的糖尿病流行病学调查,以科学的数据揭示了我国糖尿病防治的严峻形势;王国相教授等在神经遗传学方面的研究受到国内外广泛关注;晁恩祥教授等参与研制的金花清感方被确证对新甲流有效,在我国新发呼吸道传染病防治工作中做出了突出贡献。

医院的内分泌科、呼吸与危重症医学科、风湿免疫科、老年医学科、急诊医学科、胸外科、疼痛科、中医风湿病科、中西医结合肿瘤内科、中医肺病科、肛肠科、临床护理专业等科室及专业被评为国家临床重点专科建设项目。

中日医院现有副高级技术职称以上人员500余人,硕士研究生学历以上人员1000余人,博士和硕士生导师200余人。医院是北京大学和北京中医药大学的临床医学院,北京协和医学院的教学医院,与北京航空航天大学等国内学术机构建立战略合作关系,与日本、美国、英国等多个医疗机构和大学建立了友好合作关系。

医院是北京市A类定点医疗机构。当前,全院上下秉承“昌明进取,正道力行”的院训和“以教为政,为职工建设良好的事业发展平台”的核心管理理念,以“照护生命与健康”为使命,确立而立之后“一年转观念、二年入轨道、三年开局面”的阶段性发展目标,构建以业务技术管理体系和经济经营管理体系为主要内容的现代医院管理体系,共同创造中日医院更加美好的未来。


Since 1984, China Japan Friendship Hospital (hereinafter referred to as "China Japan Hospital") is a large-scale comprehensive class-A hospital directly under the national health and Health Commission, which was opened on October 23, 1984. China and Japan hospitals now have 1610 beds (including North and west districts), which are integrated with medical, teaching, scientific research, prevention and health care functions, and undertake the tasks of central health care and medical treatment, national health emergency rescue team, attached with China Japan Friendship Clinical Medicine Research Institute, who quit smoking and respiratory disease prevention cooperation center, national health and Family Planning Commission telemedicine Management and training center. Academician Wang Chen has made outstanding achievements in COPD, asthma, respiratory infection, respiratory critical illness, interstitial lung disease, pulmonary vascular disease, smoking cessation, etc. many important innovations such as pulmonary embolism half thrombolytic therapy have entered the international diagnosis and treatment guidelines. Professor Pan Xiaoren, Professor Li Guangwei and other professors have carried out "Daqing diabetes prevention research" for more than 20 years, which is called 2 The landmark research on primary prevention of type 2 diabetes is a classic of international medical research; the diabetes epidemiological survey published by Professor Yang Wenying's team in the New England Journal of medicine reveals the severe situation of diabetes prevention and treatment in China with scientific data; Professor Wang Guoxiang's research on neurogenetics has been widely concerned at home and abroad; Professor Chao Enxiang and others have participated in the research The Jinhua Qinggan formula has been proved to be effective in the prevention and treatment of new respiratory infectious diseases in China. The departments and specialties of Endocrinology, respiratory and critical care medicine, rheumatology and immunology, geriatrics, emergency medicine, thoracic surgery, pain, rheumatism of traditional Chinese medicine, internal oncology of Integrated Chinese and Western medicine, pulmonary disease of traditional Chinese medicine, anorectal surgery, clinical nursing of the hospital are rated as national key clinical specialty construction projects. At present, there are more than 500 people with associate senior technical titles or above, more than 1000 people with master's degree or above, and more than 200 doctors and master's supervisors in China and Japan hospitals. The hospital is the clinical medicine school of Peking University and Beijing University of traditional Chinese medicine, and the teaching hospital of Peking Union Medical College. It has established strategic cooperation relations with domestic academic institutions such as Beijing University of Aeronautics and Astronautics, and has established friendly cooperation relations with multiple medical institutions and universities such as Japan, the United States and the United Kingdom. The hospital is a class a designated medical institution in Beijing. At present, the whole hospital adheres to the core management concepts of "being prosperous and enterprising, being upright and doing our best" and "taking education as the government, building a good career development platform for employees", takes "caring for life and health" as the mission, establishes the phased development goal of "one year to change the concept, two years to track, three years to start", and constructs the business technology management system and economic economy The modern hospital management system with business management system as its main content will jointly create a better future for Chinese and Japanese hospitals.

本文链接: https://brand.waitui.com/f14617d1c.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

上海市副市长陈杰:加快建设人工智能“上海高地”,壮大开源社区力量

36氪获悉,2月23日,2025全球开发者先锋大会在上海徐汇召开,上海市副市长陈杰出席开幕式并发表致辞。陈杰指出,面对人工智能快速迭代、模型开源的新趋势,上海将继续发挥超大城市的综合优势,加快建设更具国际影响力的人工智能“上海高地”。进一步完善开源开放生态系统,夯实“语料开放+模型开源”服务体系,不断壮大开源社区力量,推动基础模型、算法和数据资源的共享与开放,构建开放协作、互利共赢的创新环境。(中国基金报)

35分钟前

清华AIR联合水木分子开源DeepSeek版多模态生物医药大模型BioMedGPT-R1

36氪获悉,清华大学人工智能产业研究院(AIR)和北京水木分子生物科技有限公司近日携手推出了升级版的生物医药多模态开源基础大模型BioMedGPT-R1。此前,在2023年,双方合作发布了开源可商用、生物医药多模态百亿参数开源基础大模型BioMedGPT,水木分子发布了自研千亿参数多模态生物医药专业大模型Chat DD-FM和新一代AI驱动药物发现工具Chat DD。这次DeepSeek版ChatDD- R1基座模型也已同步上线ChatDD,赋能生物医药企业的药物研发。

35分钟前

TCL李东生:中国制造未来在海外最大增量大概率来自新兴市场

36氪获悉,TCL&奥林匹克全球合作伙伴签约仪式近日在北京举行。会后,TCL创始人、董事长李东生接受记者采访时表示,当前全球产业链面临转移与重构,持续由全球化向区域化、本土化方向发展。中国制造未来在海外最大的增量空间大概率来自新兴市场,比如巴西等新兴经济体。目前TCL海外制造基地分布在越南、马来西亚、菲律宾、印尼、印度、巴基斯坦、波兰、墨西哥、巴西等九个国家,实现东南亚、南亚、欧洲、北美、南美等各大区域本土化制造布局。未来,会持续关注新兴市场的增长潜力。

35分钟前

深圳:来深毕业生免费7天住升级为15天

为方便各地高校毕业生来深找工作,深圳相继推出“青年驿站”“深梦启航”“深梦扬帆”等“深梦”系列公益活动,为各地来深高校毕业生提供免费7天居住福利,解决他们阶段性、过渡性的居住需求。 2月23日,深圳市政府新闻办召开“打造最好科技创新生态和人才发展环境”新闻发布会。市委科创委办公室主任、科技创新局局长张林在会上透露,深圳为高校应届毕业生来深求职提供免费住宿天数,将从7天延长到15天。 (深圳特区报)

35分钟前

湖南规范互联网医院处方行为:严禁使用AI等自动生成处方

36氪获悉,湖南省医保局近日发布《关于进一步加强基本医疗保障定点零售药店管理的通知》。通知中提到,规范互联网医院处方行为。对互联网医院处方有如下几个措施:①压实实体医疗机构责任。依托实体医疗机构与市级医保部门签订补充协议,强化实体医疗机构的管理责任,因互联网医院违规被解除补充协议的原则上同步解除实体医疗机构医保定点协议,依托的实体医疗机构原则上应为二级及以上医疗机构。②纳入医保管理范畴。在本统筹区提供处方服务的由本市医保中心签协议后公布,跨市州提供处方服务的先征得药店所在地市级医保中心同意,再报省医保中心审定公布。③接入处方流转平台。互联网医院须按规定接入省医保电子处方中心并进行电子处方流转。④明确处方要求。处方行为必须符合行业主管部门管理办法,应与患者或患者家属进行有效、充分的沟通问诊,严禁使用人工智能等自动生成处方。

35分钟前

本页详细列出关于郑州颐和医院的品牌信息,含品牌所属公司介绍,郑州颐和医院所处行业的品牌地位及优势。
咨询